Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 53 citing articles:

Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatment
Sophie Henneberg, Anja Hasenberg, Andreas Maurer, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes
Omer Sefvan Janjua, Muhammad Saad Shaikh, Muhammad Amber Fareed, et al.
Journal of Fungi (2021) Vol. 8, Iss. 1, pp. 44-44
Open Access | Times Cited: 43
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021)
Michael A. Pfaller, Cecília G Carvalhaes, Paul R. Rhomberg, et al.
Journal of Clinical Microbiology (2024) Vol. 62, Iss. 2
Open Access | Times Cited: 8
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017–2022)
Michael A. Pfaller, Michael D. Huband, Paul Bien, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 2
Open Access | Times Cited: 6
Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
Rohit Sharma, Praveen Kumar, Abdur Rauf, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 26
Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health
Haroldo César de Oliveira, Bárbara Tavares Bezerra, Márcio L. Rodrigues
ACS Bio & Med Chem Au (2022) Vol. 3, Iss. 2, pp. 137-146
Open Access | Times Cited: 25
The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
Asmita Ghosh, Anusua Sarkar, Pubali Paul, et al.
Fungal Biology Reviews (2021) Vol. 38, pp. 67-91
Open Access | Times Cited: 27
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections
Michael A. Pfaller, Cecília G Carvalhaes, Sean DeVries, et al.
Medical Mycology (2022) Vol. 60, Iss. 5
Open Access | Times Cited: 22
Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans
Genna E. Davies, Christopher R. Thornton
Journal of Fungi (2022) Vol. 8, Iss. 7, pp. 756-756
Open Access | Times Cited: 22
CT Appearance of Pulmonary Arteriovenous Malformations and Mimics
Demetrios A. Raptis, Ryan G. Short, Caroline L. Robb, et al.
Radiographics (2022) Vol. 42, Iss. 1, pp. 56-68
Closed Access | Times Cited: 21
Antimicrobial Silicon Rubber Crosslinked with Bornyl‐Siloxane
Chen Chen, Songtao Wang, Xinyu Chen, et al.
Macromolecular Rapid Communications (2025)
Closed Access
Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)
Michael A. Pfaller, Michael D. Huband, Paul R. Rhomberg, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 11
Open Access | Times Cited: 18
A Lateral-Flow Device for the Rapid Detection of Scedosporium Species
Genna E. Davies, Christopher R. Thornton
Diagnostics (2024) Vol. 14, Iss. 8, pp. 847-847
Open Access | Times Cited: 3
Highlights of the Latest Developments in Radiopharmaceuticals for Infection Imaging and Future Perspectives
Ekaterina Dadachova, Drauzio E.N. Rangel
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 15
The potential for rapid antigen testing for mucormycosis in the context of COVID-19
Christopher R. Thornton
Expert Review of Molecular Diagnostics (2023) Vol. 24, Iss. 3, pp. 161-167
Open Access | Times Cited: 8
Development of a monoclonal antibody and a lateral-flow device for the rapid detection of a Mucorales-specific biomarker
Christopher R. Thornton, Genna E. Davies, Laura Dougherty
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Mucormycosis medications: a patent review
Mohd Imran, Ahmed Subeh Alshrari, Mohammad Tauseef, et al.
Expert Opinion on Therapeutic Patents (2021) Vol. 31, Iss. 11, pp. 1059-1074
Closed Access | Times Cited: 18
Promising Antifungal Molecules against Mucormycosis Agents Identified from Pandemic Response Box®: In Vitro and In Silico Analyses
Mariana Ingrid Dutra da Silva Xisto, Rodrigo Rollin‐Pinheiro, Yuri de Castro-Almeida, et al.
Journal of Fungi (2023) Vol. 9, Iss. 2, pp. 187-187
Open Access | Times Cited: 7
Biosynthesis, regulation, and biological significance of fumonisins in fungi: current status and prospects
Taotao Li, Xinguo Su, Hongxia Qu, et al.
Critical Reviews in Microbiology (2021) Vol. 48, Iss. 4, pp. 450-462
Closed Access | Times Cited: 16
A Lateral-Flow Device for the Rapid Detection of Scedosporium Species
Genna E. Davies, Christopher R. Thornton
(2024)
Open Access | Times Cited: 2
Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019
Michael A. Pfaller, Cecília G Carvalhaes, Sean DeVries, et al.
Diagnostic Microbiology and Infectious Disease (2021) Vol. 102, Iss. 4, pp. 115627-115627
Open Access | Times Cited: 15
Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011–2019)
Michael A. Pfaller, Cecília G Carvalhaes, Paul R. Rhomberg, et al.
The Journal of Antibiotics (2021) Vol. 74, Iss. 8, pp. 519-527
Open Access | Times Cited: 13
Desferrioxamine B-Mediated Pre-Clinical In Vivo Imaging of Infection by the Mold Fungus Aspergillus fumigatus
Matthias Misslinger, Miloš Petřík, Joachim Pfister, et al.
Journal of Fungi (2021) Vol. 7, Iss. 9, pp. 734-734
Open Access | Times Cited: 13
Donor-Derived Transmission of Scedosporiosis in Kidney Transplant Recipients from a Systemic lupus erythematosus donor
Cheng Zeng, Yongsheng Ma, Junying Zhou, et al.
Current Medical Science (2023) Vol. 43, Iss. 2, pp. 417-420
Closed Access | Times Cited: 5
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018–2021) and application of single‐site epidemiological cutoff values to evaluate amphotericin B activity
Michael A. Pfaller, Cecília G Carvalhaes, Mariana Castanheira
Mycoses (2023) Vol. 66, Iss. 10, pp. 854-868
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top